pubmed-article:3831363 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3831363 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
pubmed-article:3831363 | lifeskim:mentions | umls-concept:C0231441 | lld:lifeskim |
pubmed-article:3831363 | lifeskim:mentions | umls-concept:C0443218 | lld:lifeskim |
pubmed-article:3831363 | lifeskim:mentions | umls-concept:C2827483 | lld:lifeskim |
pubmed-article:3831363 | lifeskim:mentions | umls-concept:C1948027 | lld:lifeskim |
pubmed-article:3831363 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3831363 | pubmed:dateCreated | 1986-5-12 | lld:pubmed |
pubmed-article:3831363 | pubmed:abstractText | Human type-A erythrocytes were lysed and solubilized with 0.3% sodium deoxy cholate (DOC). The solubilized membranes were coated onto human type-O glutaraldehyde fixed erythrocytes. The coated erythrocytes were found to agglutinate specifically by anti-A antibodies. Furthermore, solubilized membranes could be successfully coated to non-fixed erythrocytes after dialysing out the DOC. Quantitative absorption assays showed that the density of type-A blood group antigen on the coated erythrocytes was higher than the density of this antigen on human type-A erythrocytes. Erythrocytes that are coated with cell membrane antigens can be used to assess specific antibody titres and also can be applied for a sensitive selection and separation of rosetting lymphocytes that secrete specific antibodies against these antigens. | lld:pubmed |
pubmed-article:3831363 | pubmed:language | eng | lld:pubmed |
pubmed-article:3831363 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3831363 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3831363 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3831363 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3831363 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3831363 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3831363 | pubmed:month | Dec | lld:pubmed |
pubmed-article:3831363 | pubmed:issn | 0141-2760 | lld:pubmed |
pubmed-article:3831363 | pubmed:author | pubmed-author:SteinitzMM | lld:pubmed |
pubmed-article:3831363 | pubmed:author | pubmed-author:TamirSS | lld:pubmed |
pubmed-article:3831363 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3831363 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:3831363 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3831363 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3831363 | pubmed:pagination | 195-8 | lld:pubmed |
pubmed-article:3831363 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:meshHeading | pubmed-meshheading:3831363-... | lld:pubmed |
pubmed-article:3831363 | pubmed:year | 1985 | lld:pubmed |
pubmed-article:3831363 | pubmed:articleTitle | Solubilization of cell-membrane-antigen and its coupling to fixed and non-fixed erythrocytes. | lld:pubmed |
pubmed-article:3831363 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3831363 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |